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Abstract
Information on the environmental variables that may affect the incidence of invasive aspergillosis (IA) is scarce. We sought to determine the
relationship between airborne spore counts, climatic conditions and IA. We also examined whether circulating respiratory viruses
predispose patients to IA in a multicentre cohort study of hospitalized adults with IA. Data on environmental mould spores, climatic
conditions and circulating respiratory viruses were obtained from the Environmental Department of the Autonomous University of
Barcelona, the Meteorological Service of Catalonia and the Acute Respiratory Infection Surveillance Project in Catalonia, respectively.
Between 2008 and 2011, 165 patients with IA were identiﬁed. Diagnosis was based on one or more of the following: culture (125 cases),
galactomannan antigen (98) and histology (34). One hundred and twenty-seven cases (77%) had criteria for probable IA and the remainder
for proven IA. Environmental mould spore counts from the period 28–42 days preceding infection presented signiﬁcant associations with
admissions due to IA. None of the climatic conditions were associated with an increased risk of IA, but the presence of circulating
respiratory viruses was associated with a higher risk of infection: the most strongly associated viruses were respiratory syncytial virus,
inﬂuenza A(H1N1)pdm09 and adenovirus. In conclusion, the presence of high numbers of spores in the air increases the risk of admission
due to IA. Circulating respiratory viruses appear to be associated with a higher risk of developing IA. Physicians should be aware of this
association in order to optimize prevention and diagnosis strategies for IA during viral epidemic periods.
Keywords: Airborne mould counts, climatic conditions, environmental variables, invasive aspergillosis, respiratory viruses
Original Submission: 17 December 2013; Revised Submission: 14 April 2014; Accepted: 17 April 2014
Editor: E. Tacconelli
Article published online: 26 April 2014
Clin Microbiol Infect 2014; 20: O939–O945
10.1111/1469-0691.12650
Corresponding author: C. Garcia-Vidal, Infectious Disease
Department, Hospital Universitari de Bellvitge; Feixa Llarga s/n,
08907, L’Hospitalet de Llobregat, Barcelona, Spain
E-mail: carolgv75@hotmail.com
Introduction
Invasive aspergillosis (IA) is a life-threatening infection that
affects mainly severely immunocompromised patients. Despite
advances in diagnosis and treatment, mortality rates
associated with IA range from 40 to 90% [1,2]. More detailed
knowledge of factors contributing to the pathogenesis of
invasive aspergillosis is needed in order to optimize the
management of this infection and to improve prophylactic
measures.
The development of IA is a multistage process that begins
with the inhalation of conidia dispersed in the air and continues
with the host response against infection [3,4]. Individual host
factors that increase the risk of infection have been well
deﬁned [5–7]. However, our understanding of the natural
history of infection, the inocula required and the incubation
period of the disease are still poorly understood. In particular,
information regarding the possible effect of certain environ-
mental factors on the risk of IA is scarce. A previous study
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showed that climatic conditions may inﬂuence the airborne
spore count in some geographical areas [8]. However, the
relationship between climatic conditions, airborne spore
counts and rates of admission due to IA is less clear. It is
tempting to speculate that circulating respiratory viruses may
hinder the host response to infection. It could be related to an
increased risk of IA.
We sought to identify the relationship between airborne
mould spore count in the community and hospital admissions
due to IA. We also aimed to assess the effect of climatic
variables on airborne spore counts and/or the risk of IA in our
area, and whether circulating respiratory viruses predispose
patients to IA.
Methods
Setting, patients and study design
We performed a retrospective multicentre study of all
episodes of invasive aspergillosis occurring in hospitalized
adult patients between January 2008 and December 2011 at
three tertiary teaching institutions in Barcelona, Spain. Only
outpatients hospitalized for newly developed signs or symp-
toms of IA have been included. All haematological severely
immunocompromised patients stayed in rooms with strict
HEPA ﬁltration. Patients who developed IA were identiﬁed by
assessment of clinical, microbiology and pathology records,
and by review of the diagnostic codes on hospital dis-
charge. Only patients with proven and probable IA in
accordance with the deﬁnitions of the European Organization
for Research and Treatment of Cancer/National Institute of
Allergy and Infectious Diseases Mycosis Study Group (EO-
RTC/MSG) [9] were included. The following information was
carefully collected from medical records: demographic char-
acteristics, clinical features and day of IA diagnosis (the day on
which the ﬁrst diagnostic test was performed). For patients
whose diagnosis was obtained from post-mortem examina-
tion, the day of death was considered to be the day of
diagnosis.
This observational study was approved by the Institutional
Review Board.
Environmental data
Daily median airborne mould concentrations were calculated
from environmental data collected from the Institute of
Environmental Science and Technology at the Autonomous
University of Barcelona. The estimations were based on
continuous measurements taken in the centre of the city. Data
on climatic conditions were obtained from the Catalan
Meteorological Service and were based on continuous mea-
surements taken at the weather station in our urban area.
Daily median records for rainfall, measured in litres/m2,
humidity, wind and wind speed were used for the analysis.
Data on circulating respiratory viruses were obtained from the
acute respiratory infection surveillance project in Catalonia
(PIRIDAC). The numbers of cases of inﬂuenza A, inﬂuenza B,
adenovirus and respiratory syncytial virus (RSV) were used for
the study.
Statistical analysis
Categorical variables were described using counts and per-
centages. Continuous variables were expressed as the mean
and standard deviation or median and interquartile range
depending on the Kolmogorov-Smirnov test.
Patients admitted for IA were recorded according to cases
occurring during 2-week periods. The effect of environmental
variables in each 2-week period was analysed. The Spearman
q correlation was used to detect signiﬁcant temporal
associations between groups. For the analysis of quantitative
associations between environmental mould spores and
admissions due to IA in a 2-week period, a Poisson
regression model was used. To assess potential confound-
ing by environmental variables, we performed a multivariate
analysis. A partial Spearman q correlation analysis and a
Poisson relation with addition covariants were
performed. The results were analysed using SPSS version
15.0 (SPSS Inc., Chicago, IL, USA). Statistical signiﬁcance
was established at a = 0.05. All reported p-values are
two-tailed.
Results
General features of the study population
During the 4 years of the study period, 165 patients with IA
were hospitalized. The most frequent co-morbid conditions
were haematological malignancies (67 cases; 40.6%, including
13 stem cell transplantations), solid organ transplantation (33
cases; 20%), solid cancer (14 cases; 8.4%) and AIDS (nine cases;
5.4%). Other factors predisposing to IA were neutropenia (49
cases; 29.7%), corticosteroid use (87 cases, 52.7%) and use of
other immunosuppressive drugs (97 cases; 58.8%). The
diagnosis of IA was established by using one or more of the
following methods: culture (125 cases), galactomannan (98
cases) and histology (34 cases). One hundred and twenty-
seven cases (77%) had criteria for probable IA. Most cases
were caused by Aspergillus fumigatus (78.4%), followed by
A. ﬂavus (7.3%), A. terreus (4.2%) and A. niger (3.6%). Table 1
summarizes the major epidemiological and clinical character-
istics of the patients.
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Relationship between admission due to IA and environmental
airborne spore count in 2-week periods
The distribution of admissions for IA and the environmental
airborne spore count during the study period are shown in
Fig. 1. Environmental mould spore counts in the third 2-week
period (from 28 to 42 days) preceding infection presented
signiﬁcant associations with the occurrence of IA (Spearman q
correlation 0.241; p 0.014), as shown in Fig. 2. Table 2 shows
the quantitative relation between airborne spore count and
admission due to IA in the overall cohort. The presence of
environmental airborne mould spores increased the risk of IA
admission 6.021 times after the third 2-week period. This
correlation was statistically signiﬁcant. We explored con-
founding with multivariate analysis but no effect was observed.
Climatic conditions, spore counts and admission for IA
Fig. 3 shows the relationship between climatic conditions and
environmental airborne spore counts. No associations were
found between precipitation, humidity and wind and the
increase or decrease in mould spore counts in our environ-
ment in the next four 2-week periods. A relationship was
found between higher wind speed and increased environmen-
tal spore count after the second 2-week period (Spearman q
correlation 0.217; p 0.027). A second analysis did not show any
association between any climatic conditions and admissions for
IA in the next four 2-week periods. We explored confounding
with multivariate analysis but no effect was observed.
Circulating respiratory viruses, spore counts and admission
for IA
The presence of circulating respiratory viruses was not
associated with an increase or decrease in environmental
airborne mould spore counts in the next four 2-week periods.
However, the existence of circulating respiratory viruses was
associated with an increase in admissions due to IA (Fig. 4).
The relationship was particularly strong during circulating
inﬂuenza A(H1N1)pdm09 virus, adenovirus and RSV. The
circulation of inﬂuenza A(H1N1)pdm09 virus was associated
with increased hospital admissions for IA from the beginning of
the virus circulation, in the ﬁrst 2-week period and until the
second 2-week period (Spearman’s q correlation 0.304, p
0.002; 0.386, p < 0.001; 0.286, p 0.003, respectively). Adeno-
virus was associated with an increase in hospital admissions
due to IA during the circulation of the virus and the
TABLE 1. Patient baseline characteristics, clinical features
and diagnosis
Characteristic Patients, n = 165 %
Age, median years (IQR) 61 (50–68) –
Male sex 104 63
Underlying disease
Haematological malignancy 67 40.6
Solid organ transplant 33 20
Haematopoietic stem cell transplant 13 7.9
Solid tumour 14 8.4
AIDS 9 5.4
Immunodeﬁciency disorder 5 3.0
Othera 12 7.3
Immunological riskb
Neutropenia 49 29.7
Corticosteroid therapy 87 52.7
Any immunosuppressive therapy 97 58.8
Infection site
Pulmonary only 150 90.9
Disseminated IA 15 9.1
Diagnosisb
Culturec 125 75.7
Galactomannan 98 59.4
Biopsy or autopsy 34 20.6
Type of IA
Proven 38 23.0
Probable 127 77.0
aContains patients with severe immunosuppressive treatment, mainly high dose of
corticosteroids.
bPatients could have >1 characteristic within a category.
cA. fumigatus, 78.4%; A. niger, 3.6%; A. terreus, 4.2%; A. ﬂavus, 7.3%.
IA
 a
dm
is
si
on
s
0
1
2
3
4
5
6
2008 2009 2010 2011 2012
0
40
80
120
160
200
240
A
irb
or
ne
 m
ou
ld
 s
po
re
 c
ou
nt
FIG. 1. Temporal trend of IA admission and airborne mould spore count during the study period. Cases occurring during each 2-week reported
periods are shown in the bar graph, while the environmental airborne mould spore count is shown in the line graph. One hundred and four 2-week
periods were analysed. The distribution of IA admissions by the 2-week periods was as follows: twenty-ﬁve 2-week periods had no admissions for IA,
33 periods had one admission for IA, 25 periods had two admissions, nine periods had three, six periods had four, ﬁve periods had ﬁve, and one
period had six.
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subsequent 2-week period (Spearman’s q correlation 0.238, p
0.015, and 0.236, p 0.016). RSV was also associated with higher
admission for IA in the current period of circulating virus
(Spearman’s q correlation 0.242, p 0.013). No temporal
relationship was found between circulating inﬂuenza A (differ-
ent than H1N1) or inﬂuenza B and admissions due to IA.
In a second analysis, we examined the quantitative relation-
ship between airborne spore count and admission for IA in
periods with circulating respiratory viruses. Table 2 shows the
most signiﬁcant results of a Poisson regression model. The
higher the ratio, the fewer the spores required for infection.
As a summary, the airborne spore load required to produce
admission for IA was very low during the ﬁrst 2-week period
of circulation of respiratory viruses. This high correlation was
also signiﬁcant and strong during the ﬁrst 2-week periods of
inﬂuenza A, B and inﬂuenza A(H1N1)pdm09. This correlation
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FIG. 2. Temporal relationship between median airborne spore count and invasive aspergillosis admission in 2-week periods. Day 0 was the day of
invasive aspergillosis diagnosis. Correlation between median airborne spore count and invasive aspergillosis diagnosis at day 0 is shown in the vertical
line graph. The dashed line shows the p value related to a statistically signiﬁcant association (p > 0.05). The ﬁgure shows that environmental mould
spore counts in the third 2-week period (from 28 to 42 days) preceding infection have signiﬁcant association with the occurrence of IA (Spearman q
correlation 0.241; p 0.014).
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FIG. 3. Temporal relationship between climatic conditions (rainfall, humidity, wind and wind speed) and environmental airborne spore count in
2-week periods. Day 0 was the day of environmental airborne spore count determination. Correlation between climatic conditions and median
airborne spore count on day 0 is shown in the vertical line graph. The dashed line shows the p value related to a statistically signiﬁcant association
(p > 0.05). The ﬁgure shows that there were not associations between precipitation, humidity and wind and the increase or decrease in mould spore
counts in the environment in the next four 2-week periods. A relationship was found between higher wind speed and increased environmental spore
count after the second 2-week period (Spearman q correlation 0.217; p 0.027); however, association between any climatic conditions and admissions
for IA in the next four 2-week periods were not found.
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was also observed in the third 2-week period after circulating
adenovirus.
Discussion
This multicentre study of a large number of hospitalized adults
with IA found a relationship between certain environmental
factors and the risk of IA. Speciﬁcally, a high airborne mould
spore count in the period from 28 to 42 days prior to
infection was correlated with higher rates of IA diagnosis. We
did not ﬁnd an association between environmental spore
count and climatic variables in our area, or between climatic
conditions and IA admissions. Finally, we recorded a strong
relationship between circulating respiratory viruses and risk
of IA.
The results of our study coincide with those of previous
studies that have documented the relationship between
environmental mould spore counts and IA [8,10]. These
ﬁndings support the notion that a substantial proportion of
patients with IA acquired the infection outside the hospital.
The incubation period of IA has not been well deﬁned and is
probably highly variable, depending on the inhaled inocula and
host characteristics. In our cohort, which included a mix of
patients with a highly varied immunity status, we found a
strong relationship between IA admissions and high spore
counts from 28 to 42 days before the diagnosis of infection.
These data suggest that the interaction between Aspergillus and
the host begins several days prior to the current diagnosis of
IA. Establishing more prompt diagnosis of IA remains a
challenge.
Climatic conditions may affect the epidemiology of bacterial,
viral and fungal infections [11,12]. The relationship is affected
by the impact of the weather on the prevalence or virulence of
the pathogen, or by changes in host behaviours. Panackal et al.
[8] reported that climatic conditions in Seattle affected spore
counts and increased IA rates in a cohort of patients who
received haematopoietic stem cell transplants. However, they
were unable to demonstrate this association in Houston, an
area with a very different climate. In our geographical area,
climatic conditions were not associated with changes in
airborne spore counts and/or with IA. This ﬁnding suggests
that the pathogenesis of IA is complex and that geographical
differences should be taken into consideration. Moreover, the
relationship between climatic conditions and environmental
spore counts may be biased by other factors such as air
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FIG. 4. Signiﬁcant relationship between circulating respiratory viruses and invasive aspergillosis admission. Day 0 was the day of invasive
aspergillosis diagnosis. Correlation between circulating respiratory viruses and invasive aspergillosis diagnosis on day 0 is shown in the vertical line
graph. The dashed line shows the p value related to a statistically signiﬁcant association (p > 0.05). The ﬁgure shows that the circulation of inﬂuenza
A(H1N1)pdm09 virus was associated with increased hospital admissions for IA from the beginning of the virus circulation, in the ﬁrst 2-week period
and until the second 2-week period (Spearman’s q correlation 0.304, p 0.002; 0.386, p < 0.001; 0.286, p 0.003, respectively). Adenovirus was
associated with an increase in hospital admissions due to IA during the circulation of the virus and the subsequent 2-week period (Spearman’s q
correlation 0.238, p 0.015, and 0.236, p 0.016). RSV was also associated with higher admission for IA in the current period of circulating virus
(Spearman’s q correlation 0.242, p 0.013). No temporal relationship was found between circulating inﬂuenza A (different to H1N1) or inﬂuenza B and
admissions due to IA.
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pollution, land use and other modifying factors that are difﬁcult
to assess.
Interestingly, circulating respiratory viruses were associated
with an increased risk of IA. During circulating respiratory
virus periods we found that a lower airborne mould spore load
was required for IA to occur. Moreover, time to report spore
inhalation and IA was shorter, in spite of the absence of any
relationship between circulating respiratory viruses and envi-
ronmental airborne mould spore count. It is tempting to
speculate that respiratory viruses produce a major variation in
host susceptibility. It has been reported that current infection
with parainﬂuenza 3, RSV or inﬂuenza increases the patient’s
risk of developing IA [5,13–15]. Respiratory viruses alter the
bronchial mucosa, and the resulting epithelial disruption
facilitates fungal invasion. Moreover, viruses may affect local
and systemic host defences, producing a state of host adaptive
immune deﬁciency and facilitating the pathogenesis of Asper-
gillus [3].
Our study suggests that the relationship between respira-
tory viral infection and IA is signiﬁcant. Therefore, the
implementation of effective diagnostic, treatment and preven-
tion strategies for viral infections in severely immunosup-
pressed patients is of paramount importance. Primarily, a
routine search for common respiratory viruses in all immu-
nosuppressed patients complaining of symptoms of respiratory
tract infection should be performed. Prompt treatment with
oseltamivir or ribavirin when needed might help to diminish
the incidence of IA. Finally, lifelong seasonal inﬂuenza vaccina-
tion with inactivated inﬂuenza vaccine appears to be the most
effective strategy. However, the efﬁcacy of vaccines may be
compromised in this population due to insufﬁcient antigenic
response. Further information is needed in order to improve
vaccine strategies in immunocompromised patients. Another
important measure to reduce the viral load in the immuno-
suppressed host environment is the vaccination of healthcare
personnel and family members against inﬂuenza early in the
season [16,17]. Optimizing hospital or home isolation mea-
sures against viral infection, diminishing patient visits or
increasing antifungal prophylaxis in more severe immunosup-
pressed patients during circulating respiratory virus periods
should be considered.
The strengths of the current study include its inclusion of a
large cohort of consecutive hospitalized patients with IA, the
comprehensive data collection and the prospective collection
of environmental variables. Nevertheless, there are several
limitations that should be acknowledged. Firstly, this is an
observational study and residual confounding cannot be ruled
out. Moreover, due to its retrospective design, potential biases
in the selection of patients can not totally be ruled out.
Secondly, our study showed indirect evidence between viral
infection and IA admissions. It should be noted, however, that
we did not demonstrate a direct proof of a causal association
between an acute viral disease of the respiratory tract and IA.
To demonstrate the direct relationship between the virus and
the IA, a prospective study of a cohort of patients with high
risk of IA should be performed. All patients should be routinely
tested for respiratory viruses in order to avoid under-diagno-
sis of viral infection. Multivariate analysis comparing environ-
mental effects, host variables, underlying disease and
time-dependent variables, including among others duration
and dosage of steroid therapy, other immunosuppressive
treatments, neutropenia, cytomegalovirus reactivation and
presence of severe graft-vs-host disease, would be needed.
To our knowledge, this study has not been performed yet.
Thirdly, the study was carried out in a speciﬁc geographical
area. As noted above, the impact of environmental variables on
other areas may be different. Moreover, we did not ﬁnd a
relationship between climatic conditions and IA. It should be
noted, however, that data from Seattle have demonstrated a
high incidence of IA occurring just after seasonal periods of
TABLE 2. Quantitative relationship between circulating
viruses, airborne spore count and admission for IA
Quantitative
relationship
between
airborne
spore count
and IA
admission p
Overall cohort
First 2-week period preceding infection 3.717 0.119
Second 2-week period preceding infection 1.522 0.593
Third 2-week period preceding infection 6.021 0.004
All circulating virus periods
First 2-week period preceding infection 61.333 0.001
Second 2-week period preceding infection 50.162 0.145
Third 2-week period preceding infection 75.521 0.163
Circulating inﬂuenza A virus (non-H1N1)
First 2-week period preceding infection 55.322 0.003
Second 2-week period preceding infection 42.953 0.190
Third 2-week period preceding infection 81.296 0.152
Circulating inﬂuenza A(H1N1)pdm09
First 2-week period preceding infection 19.610 0.018
Second 2-week period preceding infection 3.066 0.734
Third 2-week period preceding infection 11.337 0.180
Circulating inﬂuenza B virus
Current period of infection 56.880 0.038
First 2-week period preceding infection 23.745 0.422
Second 2-week period preceding infection 12.368 0.668
Circulating adenovirus
First 2-week period preceding infection 1.275 0.684
Second 2-week period preceding infection 1.399 0.714
Third 2-week period preceding infection 4.789 0.047
Circulating respiratory syncytial virus period
First 2-week period preceding infection 0.996 0.756
Second 2-week period preceding infection 1.671 0.667
Third 2-week period preceding infection 4.529 0.063
Poisson regression coefﬁcient. This table details that the presence of environ-
mental airborne mould spores increases the risk of IA admission 6.021 times after
the third 2-week period (from 28 to 42 days) in the overall cohort. This
correlation is statistically signiﬁcant. Moreover, the table also shows the number of
spores required for infection. The higher the ratio, the fewer the spores required
for infection. Remarkably, the airborne spore load required to produce admission
for IA was very low during the ﬁrst 2-week period of circulation of respiratory
viruses. This high correlation was also signiﬁcant and strong during the ﬁrst
2-week periods of inﬂuenza A, B and pandemic A (H1N1). This correlation was
also observed in the third 2-week period after circulating adenovirus.
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low precipitation and high temperatures, which coincide with
high environmental spore counts. Fourthly, it is difﬁcult to
determine the impact of multiple variables that may affect the
risk of IA, especially those related to host-immunity; our
cohort of patients with IA had different host and prevention
strategies applied. Finally, IA is a complex disease and it is
difﬁcult to interpret time-to-event. There may be wide
variations in incidence or diagnosis depending on population,
diagnostic approach or prophylactic measures.
In summary, a high airborne mould spore count in the
environment increases the risk of IA admission in the following
28–42 days. This ﬁnding supports the idea that most IAs are
acquired outside the hospital. Circulating respiratory viruses
appear to be associated with an increased risk of developing
IA. Physicians should be aware of this association in order to
optimize the prevention and diagnosis strategies for IA during
viral epidemic periods.
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